ARHS three-lens brief
Evidence-based stock research on ARHS. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Price down 5.59% in the last session — a material single-day move. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Price down 5.59% in the last session — a material single-day move.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $10.50 — 32% above current (13 analysts).
ARHS closed at $7.94 (-5.59%) as of 2026-09-11. Market cap: $1.13B. P/E (trailing) 16.9. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $10.50 — 32% above current (13 analysts).. Concerns: price down 5.59% in the last session — a material single-day move.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $384.90M, net income $39.65M, free cash flow $79.25M.
Why three lenses on ARHS, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARHSacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARHS" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARHS brief"></iframe>